SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-13-000135
Filing Date
2013-11-06
Accepted
2013-11-05 17:54:06
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 f1030sangui10qsep2013_jfvedg.htm 10-Q 197409
2 exhibit3101.htm EX-31 7373
3 exhibit3102.htm EX-31 7884
4 exhibit3201.htm EX-32 4377
  Complete submission text file 0001551163-13-000135.txt   1001281

Data Files

Seq Description Document Type Size
5 sgbi-20130930.xml EX-101.INS 49501
6 sgbi-20130930.xsd EX-101.SCH 13449
7 sgbi-20130930_cal.xml EX-101.CAL 14781
8 sgbi-20130930_def.xml EX-101.DEF 10054
9 sgbi-20130930_lab.xml EX-101.LAB 73758
10 sgbi-20130930_pre.xml EX-101.PRE 62546
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 131193991
SIC: 2834 Pharmaceutical Preparations